Benjamin Daniels

1.9k total citations
76 papers, 1.3k citations indexed

About

Benjamin Daniels is a scholar working on Oncology, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Benjamin Daniels has authored 76 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 18 papers in Economics and Econometrics and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Benjamin Daniels's work include Health Systems, Economic Evaluations, Quality of Life (15 papers), HER2/EGFR in Cancer Research (12 papers) and Pharmaceutical Practices and Patient Outcomes (10 papers). Benjamin Daniels is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (15 papers), HER2/EGFR in Cancer Research (12 papers) and Pharmaceutical Practices and Patient Outcomes (10 papers). Benjamin Daniels collaborates with scholars based in Australia, United States and Iceland. Benjamin Daniels's co-authors include Sallie‐Anne Pearson, Emily A. Karanges, Andrea L. Schaffer, Nicholas A. Buckley, Bianca Blanch, Melisa Litchfield, Jonathan Brett, Nupur Kain, Anthony S. Don and Robyn L. Ward and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Benjamin Daniels

69 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin Daniels Australia	18	364	230	159	130	128	76	1.3k
Vanessa Rousseau France	21	250 0.7×	197 0.9×	124 0.8×	62 0.5×	73 0.6×	103	1.4k
Nayoung Han South Korea	25	377 1.0×	282 1.2×	77 0.5×	46 0.4×	111 0.9×	152	1.7k
Larry E. Fields United States	17	377 1.0×	221 1.0×	75 0.5×	110 0.8×	320 2.5×	31	2.7k
Sara Jenkins‐Jones United Kingdom	21	687 1.9×	239 1.0×	68 0.4×	59 0.5×	140 1.1×	54	2.2k
Chris D. Poole United Kingdom	25	679 1.9×	299 1.3×	79 0.5×	181 1.4×	77 0.6×	73	3.0k
Zheng Yang China	22	351 1.0×	283 1.2×	56 0.4×	61 0.5×	77 0.6×	71	1.4k
Ying Zhou China	22	322 0.9×	188 0.8×	59 0.4×	27 0.2×	59 0.5×	103	1.4k
Qin Xu China	21	317 0.9×	335 1.5×	132 0.8×	33 0.3×	127 1.0×	98	1.5k
Johnny Y. Jiang Hong Kong	15	120 0.3×	235 1.0×	85 0.5×	76 0.6×	36 0.3×	29	976
Cynthia A. Prows United States	25	380 1.0×	121 0.5×	44 0.3×	56 0.4×	345 2.7×	83	2.0k

Countries citing papers authored by Benjamin Daniels

Since Specialization

Citations

This map shows the geographic impact of Benjamin Daniels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Daniels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Daniels more than expected).

Fields of papers citing papers by Benjamin Daniels

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Daniels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Daniels. The network helps show where Benjamin Daniels may publish in the future.

Co-authorship network of co-authors of Benjamin Daniels

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Daniels. A scholar is included among the top collaborators of Benjamin Daniels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Daniels. Benjamin Daniels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Daniels, Benjamin, Tim Luckett, Winston Liauw, et al.. (2024). Trajectories of Opioid Use Before and After Cancer Diagnosis: A Population-Based Cohort Study. Journal of Pain and Symptom Management. 68(3). 282–291.e11.

Koch, Forrest, Jake Olivier, Jonathan Brett, et al.. (2024). The impact of tightened prescribing restrictions for PBS‐subsidised opioid medicines and the introduction of half‐pack sizes, Australia, 2020–21: an interrupted time series analysis. The Medical Journal of Australia. 220(6). 315–322. 6 indexed citations

Zoëga, Helga, Michael O. Falster, M. Gillies, et al.. (2024). The Medicines Intelligence Data Platform: A Population‐Based Data Resource From New South Wales, Australia. Pharmacoepidemiology and Drug Safety. 33(8). e5887–e5887. 1 indexed citations

Gisev, Natasa, Luke Buizen, Andrea L. Schaffer, et al.. (2023). Five-Year Trajectories of Prescription Opioid Use. JAMA Network Open. 6(8). e2328159–e2328159. 8 indexed citations

Lord, Sarah J., Benjamin Daniels, Dianne L. O’Connell, et al.. (2023). Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016. Cancer Epidemiology Biomarkers & Prevention. 33(2). 314–324.

Daniels, Benjamin, Marina T. van Leeuwen, M. Brown, et al.. (2023). Prevalence of Australians exposed to potentially cardiotoxic cancer medicines: a population-based cohort study. The Lancet Regional Health - Western Pacific. 39. 100872–100872.

Lord, Sarah J., Benjamin Daniels, Belinda E. Kiely, et al.. (2022). Long term risk of distant metastasis in women with non‐metastatic breast cancer and survival after metastasis detection: a population‐based linked health records study. The Medical Journal of Australia. 217(8). 402–409. 8 indexed citations

Hong, Soojung, Benjamin Daniels, Marina T. van Leeuwen, Sallie‐Anne Pearson, & Claire M. Vajdic. (2022). Incidence and risk factors of hypertension therapy in Australian cancer patients treated with vascular signalling pathway inhibitors. Discover Oncology. 13(1). 6–6. 5 indexed citations

Daniels, Benjamin, et al.. (2021). Medicine treatment of glaucoma in Australia 2012–2019: prevalence, incidence and persistence. BMJ Open Ophthalmology. 6(1). e000921–e000921. 3 indexed citations

10.

Daniels, Benjamin, Belinda E. Kiely, Mónica Tang, et al.. (2021). Trastuzumab emtansine for HER2-positive metastatic breast cancer: Outcomes from a whole-of-population Australian cohort. The Breast. 58. 106–112. 8 indexed citations

11.

Daniels, Benjamin, Sallie‐Anne Pearson, Claire M. Vajdic, et al.. (2020). Risk of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide: A population‐based case‐control study. Basic & Clinical Pharmacology & Toxicology. 127(4). 320–328. 22 indexed citations

12.

Tang, Mónica, Andrea L. Schaffer, Belinda E. Kiely, et al.. (2020). Correction: Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016). British Journal of Cancer. 123(5). 868–868. 1 indexed citations

13.

Wu, Jianyun, Scott Dickinson, Suzanne Blogg, et al.. (2020). Impact of NPS MedicineWise general practitioner education programs and Choosing Wisely Australia recommendations on prescribing of proton pump inhibitors in Australia. BMC Family Practice. 21(1). 85–85. 9 indexed citations

14.

Lord, Sarah J., Belinda E. Kiely, Sallie‐Anne Pearson, et al.. (2019). Metastatic breast cancer incidence, site and survival in Australia, 2001–2016: a population-based health record linkage study protocol. BMJ Open. 9(2). e026414–e026414. 17 indexed citations

15.

Tang, Mónica, Andrea L. Schaffer, Belinda E. Kiely, et al.. (2019). Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016). British Journal of Cancer. 121(11). 904–911. 12 indexed citations

16.

Daniels, Benjamin, Belinda E. Kiely, Sarah J. Lord, et al.. (2018). Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001–2016). Breast Cancer Research and Treatment. 171(1). 151–159. 20 indexed citations

17.

Harris, Carole A., Benjamin Daniels, Robyn L. Ward, & Sallie‐Anne Pearson. (2017). Retrospective comparison of Australia’s Pharmaceutical Benefits Scheme claims data with prescription data in HER2-positive early breast cancer patients, 2008–2012. Public Health Research & Practice. 27(5). 4 indexed citations

18.

Karanges, Emily A., Melisa Litchfield, Andrea L. Schaffer, et al.. (2015). The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers. BMC Research Notes. 8(1). 634–634. 252 indexed citations

19.

Henry, Claire, Nicholas J. Hawkins, Eve Jary, et al.. (2014). Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling. Journal of Cancer Research and Clinical Oncology. 141(2). 243–254. 59 indexed citations

20.

Russell, John H., Benjamin Daniels, & Constance A. Harrington. (2010). Variation in western redcedar heartwood extractives.. 83–86. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact